Minn. Health Officials Confirm 3 Cases of Rare Meningitis
Minnesota health officials say they've confirmed three cases of a rare fungal meningitis linked to a steroid commonly used to ease back pain.
The latest case is like the first two: a woman in her 40s, state Health Department spokesman Buddy Ferguson said Sunday. In all three cases, the women received injectable steroids that came from a compounding pharmacy in Massachusetts.
Ferguson said the third woman is hospitalized and is being treated with antibiotic and antifungal drugs. He did not know if the other two women still were hospitalized.
There are now more than 90 confirmed cases in nine states, including Minnesota, the U.S. Centers for Disease Control and Prevention said Sunday. Seven people have died; none in Minnesota.
State officials have said they believe about 950 Minnesota patients were treated with the implicated steroid products. They hoped to finish contacting all of the patients by Sunday evening.
The Minnesota health care providers known to have used the implicated drugs are Medical Advanced Pain Specialists in Edina, Fridley, Shakopee and Maple Grove, and the Minnesota Surgery Center in Edina and Maple Grove.
The steroid linked to the outbreak has been recalled, and health officials have been scrambling to notify anyone who may have received an injection of it. The Massachusetts pharmacy has said it is cooperating with investigators.
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
- Mass. Firm in Meningitis Case Eyes Bankruptcy Help
- Minn. Records 13th Illness from Tainted Steroids
- Senate Health Chair Wants New Drug Compound Rules
- Owner of Meningitis-Linked Pharmacy Takes Fifth
- Ham Lake Woman Sues After Contracting Meningitis
- Lawmakers Issue Subpoena for Pharmacy Director
- FDA Chief Will Testify at First Meningitis Hearing
- Tests Find Bacteria in Products of Mass. Pharmacy
- Meningitis Outbreak Toll: 377 Illnesses, 29 Deaths
- Mass. Firm Tied to Closed Pharmacy Issues Recall